Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Clinical Endpoints
100%
Cardiovascular Risk Markers
100%
Disease Relationships
100%
Cardiovascular Disease
25%
Cardiovascular Risk Factors
25%
Risk Factors
12%
Healthcare Professionals
12%
Early Identification
12%
Most Common Cause
12%
Cause of Death
12%
Lifestyle Modification
12%
Disease Progression
12%
Metabolic Syndrome
12%
Cardiovascular Risk
12%
Risk Stratification
12%
Screening Risks
12%
Medical Treatment
12%
Vasodilatory
12%
Risk Identification
12%
Surrogate Marker
12%
Common Diagnoses
12%
Intervention Effectiveness
12%
Current Management
12%
Brachial Artery
12%
Liver Biopsy
12%
Carotid Intima-media Thickness (cIMT)
12%
Coronary Artery Calcium Score
12%
Clinical Methods
12%
Carotid Plaque
12%
Serum Biomarker Panel
12%
Hepatic Ultrasound
12%
Cardiac Magnetic Resonance Imaging (cMRI)
12%
Management Strategies
12%
Screening Diagnosis
12%
Medicine and Dentistry
Cardiovascular Risk
100%
Nonalcoholic Fatty Liver
100%
Clinical Endpoint
100%
Cardiovascular Disease
25%
Prevalence
12%
Lifestyle Modification
12%
Risk Stratification
12%
Metabolic Syndrome
12%
Magnetic Resonance Imaging
12%
Clinical Method
12%
Biological Marker
12%
Disease Marker
12%
Brachial Artery
12%
Liver Biopsy
12%
Intima-Media Thickness
12%
Coronary Artery Calcification
12%
Diseases
12%
Health Care Personnel
12%
Healthcare Professional
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Risk
100%
Nonalcoholic Fatty Liver
100%
Cardiovascular Disease
25%
Prevalence
12%
Biological Marker
12%
Metabolic Syndrome X
12%
Disease Marker
12%
Diseases
12%
Coronary Artery Calcification
12%